# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-27T16:29:36.521669
**Route:** OpenRouter + LaTeX
**Paper Hash:** 35b9d8bed741b5ee
**Tokens:** 16649 in / 1565 out
**Response SHA256:** 577cc432784e5fc3

---

FATAL ERROR 1: Internal Consistency (Treatment definition vs. Randomization Inference procedure)
  Location: Main text (Abstract + Introduction + Robustness section) vs. Appendix C “Randomization Inference Details”
  Error:
  - Throughout the paper you define the treated group as **244 ACV communes** (222 original + 22 later additions) and you estimate TWFE on a panel with **244 treated + 58 controls = 302 communes** (18,120 commune-quarters).
  - But the Randomization Inference (RI) procedure in Appendix C says: “randomly assigns ACV status to **222** out of all eligible communes …”
  - That RI procedure does **not** correspond to your actual treatment definition used in the main regressions (244 treated). If you permute 222 “treated” labels while your actual design treats 244 communes, the RI p-value you report (0.463 / 0.46) is not interpretable as a p-value for the main estimand/specification.
  Why this is fatal:
  - It is a direct mismatch between the design described/estimated and the inference method used to validate the result. A journal referee will likely flag this as a basic design/inference inconsistency.
  How to fix:
  - Choose one and make it consistent everywhere:
    1) **If the main treatment group is 244**, then in RI you must permute **244** treated labels (not 222), with the same sample, outcome, FE structure, and clustering as the main TWFE.
    2) **If RI must be based on 222** (e.g., because “eligible communes” are defined for the original rollout), then the *main analysis* and all headline results (abstract, Table 3/“main,” figures) must be redefined to use the **original 222-only treated sample**, and the rest of the paper must match that definition.
  - Also ensure the RI description matches the main text claim “permutes ACV designation across all eligible communes” (define eligibility set precisely and keep it constant across baseline/robustness).

FATAL ERROR 2: Internal Consistency (Number of pre-treatment event-study quarters)
  Location: Introduction + Empirical Strategy (“24 pre-treatment quarters (2012Q1–2017Q4)”) vs. Results “Event Study” paragraph (“k = -20 to k = -2”)
  Error:
  - You repeatedly claim **24 pre-treatment quarters** are used to validate parallel trends (2012Q1–2017Q4).
  - But in the Results narrative you describe the pre-period coefficients as “**k = -20 to k = -2**,” which corresponds to **19** pre-treatment coefficients (and implies a shorter pre window than stated), unless you are top-coding bins and not saying so.
  Why this is fatal:
  - This is a hard, checkable mismatch about the time window underlying the central identification diagnostic (pre-trends). It strongly suggests either the figure/event-time coding is different from what the paper claims, or the text is wrong.
  How to fix:
  - Make the event-time indexing consistent with the stated pre-period:
    - If pre is 2012Q1–2017Q4 with reference 2017Q4 (k = -1), then the earliest pre quarter corresponds to **k = -24** and you should describe/report pre coefficients as **k = -24 to -2** (with k=-1 omitted as reference).
    - If you intentionally restrict to fewer pre quarters (e.g., -20 to -2), then you must revise *everywhere* that says “24 pre-treatment quarters” and update the stated pre-period dates accordingly.
  - Confirm the plotted figure (Fig. 2) and the regression code actually use the same window you describe.

ADVISOR VERDICT: FAIL